Correlation Between Hillstream Biopharma and Neurobo Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Hillstream Biopharma and Neurobo Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hillstream Biopharma and Neurobo Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Hillstream Biopharma and Neurobo Pharmaceuticals, you can compare the effects of market volatilities on Hillstream Biopharma and Neurobo Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hillstream Biopharma with a short position of Neurobo Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hillstream Biopharma and Neurobo Pharmaceuticals.

Diversification Opportunities for Hillstream Biopharma and Neurobo Pharmaceuticals

0.75

Correlation Coefficient

Hillstream Biopharma  Neurobo Pharmaceuticals

Poor diversification

The 3 months correlation between Hillstream and Neurobo is 0.75. Overlapping area represents the amount of risk that can be diversified away by holding Hillstream Biopharma and Neurobo Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neurobo Pharmaceuticals and Hillstream Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hillstream Biopharma are associated (or correlated) with Neurobo Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neurobo Pharmaceuticals has no effect on the direction of Hillstream Biopharma i.e., Hillstream Biopharma and Neurobo Pharmaceuticals go up and down completely randomly.

Pair Corralation between Hillstream Biopharma and Neurobo Pharmaceuticals

If you would invest  39.00  in Hillstream Biopharma on September 14, 2024 and sell it today you would earn a total of  0.00  from holding Hillstream Biopharma or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	1.61%
Values	Daily Returns

Hillstream Biopharma  vs.  Neurobo Pharmaceuticals

Hillstream Biopharma

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Hillstream Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable essential indicators, Hillstream Biopharma is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Neurobo Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Neurobo Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's fundamental drivers remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pair Trading with Hillstream Biopharma and Neurobo Pharmaceuticals

The main advantage of trading using opposite Hillstream Biopharma and Neurobo Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hillstream Biopharma position performs unexpectedly, Neurobo Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neurobo Pharmaceuticals will offset losses from the drop in Neurobo Pharmaceuticals' long position.

The idea behind Hillstream Biopharma and Neurobo Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.